Page last updated: 2024-12-08

phosphoglycocyamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

phosphoguanidinoacetic acid : A guanidinoacetate having a phospho group attached to the primary amino part of the guanidine moiety. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID188984
CHEMBL ID1206371
CHEBI ID16034
SCHEMBL ID7831295
SCHEMBL ID9618025
MeSH IDM0081509

Synonyms (19)

Synonym
CHEBI:16034 ,
phosphoguanidinoacetic acid
(n'-phosphonocarbamimidamido)acetic acid
n-[imino(phosphonoamino)methyl]glycine
(n'-phosphonoguanidino)acetic acid
phosphoguanidinoacetate
C03166
guanidinoacetate phosphate
phosphoglycocyamine
5115-19-5
2-[[amino-(phosphonoamino)methylidene]amino]acetic acid
CHEMBL1206371
n-(imino(phosphonoamino)methyl)glycine
SCHEMBL7831295
SCHEMBL9618025
2-[(e)-[amino(phosphonoamino)methylidene]amino]acetic acid
DTXSID30199173
n-(n-phosphonoamidino)glycine
Q27098344
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
guanidinoacetic acids
phosphoramideA compound in which one or more of the OH groups of phosphoric acid have been replaced with an amino or substituted amino group. The term is commonly confined to the phosphoric triamides, P(=O)(NR2)3, since replacement of one or two OH groups produces phosphoramidic acids: P(=O)(OH)(NR2)2 , P(=O)(OH)2(NR2).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (4)

PathwayProteinsCompounds
Creatine pathway116
Biochemical pathways: part I0466
Amino acid metabolism094
Urea cycle and metabolism of amino groups2116

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]